PP

PAUL PEREIRA

ARDELYX, INC. · Freemont, CA · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
3 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Freemont, CA
2024 - present

Specific issues

H.R.5074 - Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 - To delay incorporation of oral drugs indicated for the reduction, management, or control of the serum phosphate of an individual into the End-Stage Renal Disease (ESRD) Prospective Payment System. S.4510 - A bill to amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.
Health Issues · 2024 Q4
H.R.5074 - Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 - To delay incorporation of oral drugs indicated for the reduction, management, or control of the serum phosphate of an individual into the End-Stage Renal Disease (ESRD) Prospective Payment System.
Health Issues · 2024 Q1

Clients

2024 · 4 filings
$██,███ / qtrUnlock

Filing history

2024 Q4
ARDELYX, INC.
Q4lda.gov →
2024 Q3
ARDELYX, INC.
Q3lda.gov →
2024 Q2
ARDELYX, INC.
Q2lda.gov →
2024 Q1
ARDELYX, INC.
Q1lda.gov →
Showing recent filings · full history on lda.gov